| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Piero Ruggenenti | Q92877106 |
| Paola Bettinaglio | Q114428677 | ||
| Giuseppe Remuzzi | Q16561003 | ||
| P2093 | author name string | Franck Pinares | |
| P2860 | cites work | Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy | Q79799476 |
| Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis | Q80174566 | ||
| Glomerular mesangium: its function and relationship to angiotensin II | Q93627517 | ||
| Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study | Q31961591 | ||
| Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. | Q33898817 | ||
| Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications | Q34126269 | ||
| The preparation and function of the hypertensin-converting enzyme | Q34238210 | ||
| An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
| The existence of two forms of hypertensin | Q34648778 | ||
| Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents | Q34936463 | ||
| Two point mutations within the adducin genes are involved in blood pressure variation | Q35210045 | ||
| Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage | Q35604343 | ||
| Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy | Q35765753 | ||
| ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients | Q35937633 | ||
| Erythrocyte adducin differential properties in the normotensive and hypertensive rats of the Milan strain. Characterization of spleen adducin m-RNA. | Q35984419 | ||
| Preventing end stage renal disease in diabetic patients--genetic aspect (part I). | Q36223159 | ||
| STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA. | Q36254330 | ||
| Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study | Q36600164 | ||
| ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy | Q36666911 | ||
| Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor | Q36789015 | ||
| Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group | Q37365616 | ||
| A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro | Q37365783 | ||
| The role of intraglomerular pressure in the initiation and progression of renal disease | Q39508707 | ||
| Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy | Q40554813 | ||
| The purification of hypertensin I. | Q42821638 | ||
| The amino acid sequence of hypertensin. II. | Q42822342 | ||
| The preparation, purification, and amino acid sequence of a polypeptide renin substrate | Q42822581 | ||
| ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus | Q43507635 | ||
| Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. | Q43717170 | ||
| Renal function in relation to three candidate genes | Q43812614 | ||
| Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? | Q43905227 | ||
| Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake | Q43931492 | ||
| Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype? | Q44039629 | ||
| Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype? | Q44418831 | ||
| Effects of the Genetic Polymorphisms of the Renin-Angiotensin System on Focal Segmental Glomerulosclerosis | Q44650726 | ||
| Interaction between gene polymorphisms of nitric oxide synthase and renin-angiotensin system in the progression of membranous glomerulonephritis. | Q44758537 | ||
| Angiotensin-converting enzyme gene polymorphism in children with idiopathic nephrotic syndrome. | Q44982668 | ||
| Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy | Q45056467 | ||
| Molecular basis of human hypertension: role of angiotensinogen | Q45118696 | ||
| Polymorphism of renin-angiotensin system genes in IgA nephropathy | Q45123574 | ||
| Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients | Q45125171 | ||
| Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. | Q45242349 | ||
| Angiotensin II causes mesangial cell hypertrophy | Q46347884 | ||
| Influence of angiotensin-converting enzyme gene polymorphism on the anti-proteinuria efficacy of angiotensin-converting enzyme inhibitor in Han nationality of southern Sichuan province in China | Q46406904 | ||
| Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients | Q46722535 | ||
| Pharmacogenetics of angiotensin system in non diabetic nephropathy | Q46758318 | ||
| Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients | Q47729945 | ||
| Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. | Q50657861 | ||
| Suggested Revision of Nomenclature--Angiotensin. | Q50736845 | ||
| Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. | Q50897511 | ||
| Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. | Q52900559 | ||
| Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism. | Q53589095 | ||
| Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes. | Q54102347 | ||
| Receptors for angiotensin I and II. | Q54302875 | ||
| Angiotensin converting enzyme gene polymorphisms do not predict the course of idiopathic nephrotic syndrome in Swiss children. | Q54564581 | ||
| Influence of gender and genetic variability on plasma angiotensin peptides. | Q54573065 | ||
| Alpha-adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria. | Q54608999 | ||
| Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism. | Q54623917 | ||
| Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. | Q54624994 | ||
| ACE gene insertion/deletion polymorphism in childhood idiopathic nephrotic syndrome. | Q54637866 | ||
| ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndrome. | Q54728337 | ||
| Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis | Q56893651 | ||
| Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy: Case-Control, Haplotype, and Family-Based Study in Three European Populations | Q57312423 | ||
| Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries | Q57703168 | ||
| The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) | Q57703684 | ||
| ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1 | Q57703755 | ||
| Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen | Q57703762 | ||
| Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease | Q58132961 | ||
| Amino-Acid Sequence in a Hypertensin | Q59069186 | ||
| Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy | Q59489273 | ||
| Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy | Q59697087 | ||
| Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects | Q61771206 | ||
| Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease | Q61855335 | ||
| Proceedings of a symposium: Calcium metabolism and calcium channel blockers for understanding and treating hypertension | Q70728586 | ||
| A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene | Q70908032 | ||
| Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria | Q71373746 | ||
| Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy | Q71568739 | ||
| Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus | Q71612671 | ||
| Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension | Q72036783 | ||
| Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics | Q72390623 | ||
| Effect of a polymorphism of endothelial nitric oxide synthase gene in Japanese patients with IgA nephropathy | Q73136876 | ||
| Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension | Q73186366 | ||
| Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes | Q73235838 | ||
| Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan | Q73340931 | ||
| Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) | Q73499190 | ||
| ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients | Q73621995 | ||
| Gene-polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis | Q73834028 | ||
| Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy | Q73884598 | ||
| Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status | Q73960800 | ||
| Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program | Q74020669 | ||
| Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Gènes de l'Hypertension Artérielle Sévère à modérée Essentielle | Q74418601 | ||
| Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal D | Q74772266 | ||
| Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in ID | Q77191848 | ||
| Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients | Q77867095 | ||
| Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients | Q77893800 | ||
| [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis] | Q78041530 | ||
| [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes] | Q78642301 | ||
| Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism and IgA nephropathy: a meta-analysis | Q79379740 | ||
| Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy | Q79401871 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 1511-1525 | |
| P577 | publication date | 2008-06-11 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies | |
| P478 | volume | 3 |
| Q63440925 | ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes |
| Q62071571 | ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria |
| Q30486653 | ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. |
| Q42252954 | AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy. |
| Q34385868 | AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients |
| Q48320229 | Achieving remission of proteinuria in childhood CKD. |
| Q38783172 | Albuminuria is associated with a higher prevalence of depression in a population-based cohort study: the Maastricht Study |
| Q37624275 | Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism and Vesicoureteral Reflux in Children: A Meta-Analysis of 14 Case-Control Studies |
| Q36039299 | Angiotensin II revisited: new roles in inflammation, immunology and aging |
| Q37758534 | Application of direct renin inhibition to chronic kidney disease |
| Q33586532 | Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus |
| Q30433474 | Associations between genetic variants in the ACE, AGT, AGTR1 and AGTR2 genes and renal function in the Multi-ethnic Study of Atherosclerosis |
| Q34687442 | Childhood course of renal insufficiency in a family with a uromodulin gene mutation |
| Q41123351 | Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes. |
| Q54342371 | Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran. |
| Q26999279 | Developments in renal pharmacogenomics and applications in chronic kidney disease |
| Q46102744 | Differential ACE expression among tissues in allele-specific Wistar rat lines |
| Q43236381 | Emerging risk factors and markers of chronic kidney disease progression |
| Q42142772 | Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney |
| Q26825851 | Genome-wide association studies of chronic kidney disease: what have we learned? |
| Q38191126 | How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients? |
| Q35141509 | Hyperglycemia enhances kidney cell injury in HIVAN through down-regulation of vitamin D receptors |
| Q34812460 | Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease |
| Q38527798 | Identifying Common Genetic Risk Factors of Diabetic Neuropathies |
| Q36309378 | Inhibition of renin activity slows down the progression of HIV-associated nephropathy |
| Q36623841 | Integrative Biology of Diabetic Kidney Disease |
| Q91046009 | Kidney disease trials for the 21st century: innovations in design and conduct |
| Q37671280 | Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women |
| Q37646842 | Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. |
| Q51075506 | Post-renal transplant erythrocytosis: a case report. |
| Q34776598 | Protein kinase C-β gene variants and type 2 diabetes-associated kidney failure: What can we learn from gene association studies in diabetic nephropathy? |
| Q35974821 | Rat Ace allele variation determines susceptibility to AngII-induced renal damage |
| Q42723231 | Role of the renin angiotensin system in diabetic nephropathy |
| Q35720736 | Sodium intake, ACE inhibition, and progression to ESRD. |
| Q37741783 | The RAAS in the pathogenesis and treatment of diabetic nephropathy |
| Q51496563 | The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan. |
| Q62071585 | The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria |
| Q54478891 | The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes. |
| Q27000456 | The kallikrein-kinin system and oxidative stress |
| Q26827473 | The kallikrein-kinin system in diabetic nephropathy |
| Q36285918 | Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine |
Search more.